Surface plasmon resonance analysis of topoisomerase I-DNA binding: Effect of Mg2+ and DNA sequence

Anti-Cancer Drugs

Volumn 8, Issue 4, 1997, Pages 336-344

  Pond, Christopher D ^a   Holden, Joseph A ^b   Schnabel, Peter C ^a   Barrows, Louis R ^a  

^a UNIVERSITY OF UTAH   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

BIAcore; DNA binding; Kinetics; Surface plasmon resonance; Topoisomerase I

Indexed keywords

DNA TOPOISOMERASE; MAGNESIUM;

ARTICLE; CONTROLLED STUDY; DNA BINDING; KINETICS; PRIORITY JOURNAL;

EID: 0030961269     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001813-199704000-00005     Document Type: Article

References (31)

1. Malmqvist M, Granzow R. Biomolecular interaction analysis. Methods 1994; 6: 95-8.
2. Granzow R, Reed R. Interactions in the fourth dimension. Bio/technology 1992; 10: 390-3.
3. Fisher RJ, Fivash M, Casas-Finet, Balden S, McNitt KL. Real-time BIAcore measurements of Escherichia coli single-stranded DNA binding (SSB) protein to polydeoxythymidylic acid reveal single-state kinetics with steric cooperativity. Methods 1994; 6: 121-33.
4. O'Shannessy DJ, Brigham-Burke M, Sonenson KK, Hensley P, Brooke I. Determination of rate and equilibrium binding constants for macromolecular interactions using surface plasmon resonance: use of nonlinear least squares analysis methods. Anal Biochem 1993; 212: 457-68.
5. Wang JC. DNA topoisomerase. Annu Rev Biochem 1996; 65: 635-92.
6. D'Arpa P, Liu LF. Topoisomerase targeting antitumor drugs. Biochem Biophys Acta 1989; 989: 163-77.
7. Chabner BA, Allegra CJ, Curt GA, Calabresi P. Antineoplastic agents. In: Hardman JG, Linbird LE, Molinoff PB, Ruddon RW, Gilman AG, eds. The pharmacological basis of therapeutics, 9th edn. New York: McGraw-Hill 1996.
8. Wigley DB. Structure and mechanisms of topoisomerases. Annu Rev Biophys Biomol Struct 1995; 24: 185-208.
9. Campoux J. Evidence for an intermediate with a single-strand break in the reaction catalyzed by the DNA untwisting enzyme. Proc Natl Acad Sci USA 1976; 73: 3488-91.
10. Stewart L, Ireton GC, Parker LH, Madden KR, Champoux JJ. Biochemical and biophysical analyses of recombinant forms of human topoisomerase I. J Biol Chem 1996; 271: 7593-601.
11. Von Hoff DD, Burris III HA, Eckardt J, et al. Preclinical and phase I trials of topoisomerase I inhibitors. Chemother Pharmacol 1994; 34: S41-4.
12. Caserta M, Amadei A, Camilloni G, Di Mauro E. Regulation of the function of eukaryotic topoisomerase I: analysis of the binding step and of the catalytic constants of topoisomerization as a function of DNA topology. Biochemistry 1990; 29: 8152-7.
13. Pulleybank DE, Ellison MJ. Purification and properties of type I topoisomerase from chicken erythrocytes: Mechanism of eukaryotic topoisomerase action. Biochemistry 1982; 21: 1155-61.
14. Nelson HCM. Structure and function of DNA-binding proteins. Curr Opin Genet Dev 1995; 5: 180-9.
15. Christiansen K, Westergaard O. Characterization of intra- and intermolecular DNA ligation mediated by eukaryotic topoisomerase I. J Biol Chem 1994; 269: 721-9.
16. Camilloni G, Caserta M, Amadei A, Di Mauro E. The conformation of constitutive DNA interaction sites for eukaryotic DNA topoisomerase I on intrinsically curved DNAs. Biochem Biophys Acta 1991; 1129: 73-82.
17. Krough S, Mortensen UH, Westergaard O, Bonven BJ. Eukaryotic topoisomerase I-DNA interaction is stabilized by helix curvature. Nucleic Acids Res 1991; 19: 1235-41.
18. Domanico PL, Tse-Dinh YC. Mechanistic studies on E. coli DNA topoisomerase I: divalent Ion effects. J Inorg Biochem 1991; 42: 87-96.
19. Svejstrup JQ, Christiansen K, Gromova II, Andersen AH, Westergaard O. New technique for uncoupling the cleavage and religation of eukaryotic topoisomerase I. J Mol Biol 1991; 222: 669-78.
20. 2+, Asp-, and Glu-effects in the processive and distributive DNA relaxation catalyzed by eukaryotic topoisomerase I. Biochemistry 1991; 30: 9940-7.
21. Stivers JT, Shuman S, Mildvan AS. Vaccinia DNA topoisomerase I: single-turnover and steady-state kinetic analysis of the DNA strand cleavage and ligation reactions. Biochemistry 1994; 33: 327-39.
22. Maniatis T, Fritsh EF, Sambrook J, eds. Molecular cloning: a laboratory manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press 1982.
23. Holden JA, Rolfson DH, Low RL. DNA topoisomerase I from human placenta. Biochim Biophys Acta 1990; 1049: 303-10.
24. BIAevaluation 2.1, Software Handbook, Edition January 1995. Pharmacia Biosensor AB.
25. O'Shannessy DJ. Determination of kinetic rate and equilibrium binding constants for macromolecular interactions: a critique of the surface plasmon resonance literature. Curr Opin Biotechnol 1994; 5: 65-71.
26. Negri R, Costanzo G, Buttinelli M, Venditti S, Di Mauro E. Effects of DNA topology in the interaction with histone octamers and DNA topoisomerase I. Biophys Chem 1991; 50: 169-81.
27. Thiyagarajan MM, Kotani H, Holloman WK, Kmiec EB. DNA relaxation mediated by Ustilago maydis type I topoisomerase; modulation by chromatin associated proteins. Biochem Biophys Acta 1993; 1173: 155-64.
28. Jaxel C, Kohn KW, Pommier Y. Topoisomerase I interaction with SV40 DNA in the presence and absence of camptothecin. Nucleic Acids Res 1988; 16: 11157-71.
29. Porter SE, Champoux JJ. The basis for camptothecin enhancement of DNA breakage by eukaryotic topoisomerase I. Nucleic Acids Res 1989; 17: 8521-32.
30. Diekmann S. Temperature and salt dependence of the gel migration anomaly of curved DNA fragments. Nucleic Acids Res 1987; 15: 247-65.
31. 25Mg-NMR relaxation rates: field and coion dependence. Biopolymers 1994; 34: 691-700.